Legal Representation
Attorney
PETER J RIEBLING
USPTO Deadlines
Next Deadline
1855 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-08-20)
Due Date
August 20, 2030
Grace Period Ends
February 20, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 1, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Mar 1, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Feb 13, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Feb 13, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Feb 10, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 8, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Nov 21, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 20, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 20, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 4, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 15, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 8, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Apr 29, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 29, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 29, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 17, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Apr 16, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 29, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 28, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 27, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 27, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 27, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 27, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 27, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 12, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Sep 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 7, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 035
Providing business advice, information and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; providing business information about pharmaceutical, biopharmaceutical and medical device products and companies; market research for the pharmaceutical, biopharmaceutical and medical device industries; business research and market analysis for the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, strategic consulting and assistance with business decisions in the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, competitor landscaping, competitor monitoring, business competitive intelligence for the pharmaceutical biopharmaceutical and medical device industries; preparing reports on all the aforesaid
Class 042
Providing scientific and technological information, advice and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific research and analysis for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific and technological landscaping for the pharmaceutical, biopharmaceutical and medical device industries; quality control for others, namely, assessment and benchmarking of pharmaceutical, biopharmaceutical and medical device products; quality control for others, namely, researching, analysing and assessment of pharmaceutical, biopharmaceutical and medical device products for others; providing scientific information about pharmaceutical, biopharmaceutical and medical device products and companies; scientific research consulting, namely, preparing advice and reports on all the aforesaid
Classification
International Classes
035
042